Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Routine issuance of clinical magnets to patients receiving implantable defibrillators: retention of information and appropriateness of use.

Open heart

Thomas DE, Barry JP, Churchouse W, Anderson MH.
PMID: 26019880
Open Heart. 2015 May 20;2(1):e000224. doi: 10.1136/openhrt-2014-000224. eCollection 2015.

BACKGROUND: The application of a clinical magnet over an implantable cardioverter defibrillator (ICD) can be used to suspend tachycardia therapies in patients receiving recurrent or inappropriate shocks. In our institution, they have been routinely issued to patients undergoing ICD...

Cite
Thomas DE, Barry JP, Churchouse W, et al. Routine issuance of clinical magnets to patients receiving implantable defibrillators: retention of information and appropriateness of use. Open Heart. 2015;2(1):e000224doi: 10.1136/openhrt-2014-000224.
Thomas, D. E., Barry, J. P., Churchouse, W., & Anderson, M. H. (2015). Routine issuance of clinical magnets to patients receiving implantable defibrillators: retention of information and appropriateness of use. Open heart, 2(1), e000224. https://doi.org/10.1136/openhrt-2014-000224
Thomas, Dewi E, et al. "Routine issuance of clinical magnets to patients receiving implantable defibrillators: retention of information and appropriateness of use." Open heart vol. 2,1 (2015): e000224. doi: https://doi.org/10.1136/openhrt-2014-000224
Thomas DE, Barry JP, Churchouse W, Anderson MH. Routine issuance of clinical magnets to patients receiving implantable defibrillators: retention of information and appropriateness of use. Open Heart. 2015 May 20;2(1):e000224. doi: 10.1136/openhrt-2014-000224. eCollection 2015. PMID: 26019880; PMCID: PMC4442150.
Copy Download .nbib Format: NLM
A data harmonization pipeline to leverage external controls and boost power in GWAS.

Human molecular genetics

Chen D, Tashman K, Palmer DS, Neale B, Roeder K, Bloemendal A, Churchhouse C, Ke ZT.
PMID: 34508597
Hum Mol Genet. 2021 Sep 11; doi: 10.1093/hmg/ddab261. Epub 2021 Sep 11.

The use of external controls in genome-wide association study (GWAS) can significantly increase the size and diversity of the control sample, enabling high-resolution ancestry matching and enhancing the power to detect association signals. However, the aggregation of controls from...

Cite
Chen D, Tashman K, Palmer DS, et al. A data harmonization pipeline to leverage external controls and boost power in GWAS. Hum Mol Genet. 2021;doi: 10.1093/hmg/ddab261.
Chen, D., Tashman, K., Palmer, D. S., Neale, B., Roeder, K., Bloemendal, A., Churchhouse, C., & Ke, Z. T. (2021). A data harmonization pipeline to leverage external controls and boost power in GWAS. Human molecular genetics, . https://doi.org/10.1093/hmg/ddab261
Chen, Danfeng, et al. "A data harmonization pipeline to leverage external controls and boost power in GWAS." Human molecular genetics vol. (2021). doi: https://doi.org/10.1093/hmg/ddab261
Chen D, Tashman K, Palmer DS, Neale B, Roeder K, Bloemendal A, Churchhouse C, Ke ZT. A data harmonization pipeline to leverage external controls and boost power in GWAS. Hum Mol Genet. 2021 Sep 11; doi: 10.1093/hmg/ddab261. Epub 2021 Sep 11. PMID: 34508597.
Copy Download .nbib Format: NLM
Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines.

Journal of Crohn's & colitis

Porter RJ, Arends MJ, Churchhouse AMD, Din S.
PMID: 34111282
J Crohns Colitis. 2021 Dec 18;15(12):2131-2141. doi: 10.1093/ecco-jcc/jjab102.

The cumulative impact of chronic inflammation in patients with inflammatory bowel diseases predisposes to the development of inflammatory bowel disease-associated colorectal cancer [IBD-CRC]. Inflammation can induce mutagenesis, and the relapsing-remitting nature of this inflammation, together with epithelial regeneration, may...

Cite
Porter RJ, Arends MJ, Churchhouse AMD, et al. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines. J Crohns Colitis. 2021;15(12):2131-2141doi: 10.1093/ecco-jcc/jjab102.
Porter, R. J., Arends, M. J., Churchhouse, A. M. D., & Din, S. (2021). Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines. Journal of Crohn's & colitis, 15(12), 2131-2141. https://doi.org/10.1093/ecco-jcc/jjab102
Porter, Ross J, et al. "Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines." Journal of Crohn's & colitis vol. 15,12 (2021): 2131-2141. doi: https://doi.org/10.1093/ecco-jcc/jjab102
Porter RJ, Arends MJ, Churchhouse AMD, Din S. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines. J Crohns Colitis. 2021 Dec 18;15(12):2131-2141. doi: 10.1093/ecco-jcc/jjab102. PMID: 34111282.
Copy Download .nbib Format: NLM
Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines.

Journal of Crohn's & colitis

Porter RJ, Arends MJ, Churchhouse AMD, Din S.
PMID: 34111282
J Crohns Colitis. 2021 Dec 18;15(12):2131-2141. doi: 10.1093/ecco-jcc/jjab102.

The cumulative impact of chronic inflammation in patients with inflammatory bowel diseases predisposes to the development of inflammatory bowel disease-associated colorectal cancer [IBD-CRC]. Inflammation can induce mutagenesis, and the relapsing-remitting nature of this inflammation, together with epithelial regeneration, may...

Cite
Porter RJ, Arends MJ, Churchhouse AMD, et al. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines. J Crohns Colitis. 2021;15(12):2131-2141doi: 10.1093/ecco-jcc/jjab102.
Porter, R. J., Arends, M. J., Churchhouse, A. M. D., & Din, S. (2021). Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines. Journal of Crohn's & colitis, 15(12), 2131-2141. https://doi.org/10.1093/ecco-jcc/jjab102
Porter, Ross J, et al. "Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines." Journal of Crohn's & colitis vol. 15,12 (2021): 2131-2141. doi: https://doi.org/10.1093/ecco-jcc/jjab102
Porter RJ, Arends MJ, Churchhouse AMD, Din S. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines. J Crohns Colitis. 2021 Dec 18;15(12):2131-2141. doi: 10.1093/ecco-jcc/jjab102. PMID: 34111282.
Copy Download .nbib Format: NLM
Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines.

Journal of Crohn's & colitis

Porter RJ, Arends MJ, Churchhouse AMD, Din S.
PMID: 34111282
J Crohns Colitis. 2021 Dec 18;15(12):2131-2141. doi: 10.1093/ecco-jcc/jjab102.

The cumulative impact of chronic inflammation in patients with inflammatory bowel diseases predisposes to the development of inflammatory bowel disease-associated colorectal cancer [IBD-CRC]. Inflammation can induce mutagenesis, and the relapsing-remitting nature of this inflammation, together with epithelial regeneration, may...

Cite
Porter RJ, Arends MJ, Churchhouse AMD, et al. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines. J Crohns Colitis. 2021;15(12):2131-2141doi: 10.1093/ecco-jcc/jjab102.
Porter, R. J., Arends, M. J., Churchhouse, A. M. D., & Din, S. (2021). Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines. Journal of Crohn's & colitis, 15(12), 2131-2141. https://doi.org/10.1093/ecco-jcc/jjab102
Porter, Ross J, et al. "Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines." Journal of Crohn's & colitis vol. 15,12 (2021): 2131-2141. doi: https://doi.org/10.1093/ecco-jcc/jjab102
Porter RJ, Arends MJ, Churchhouse AMD, Din S. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines. J Crohns Colitis. 2021 Dec 18;15(12):2131-2141. doi: 10.1093/ecco-jcc/jjab102. PMID: 34111282; PMCID: PMC8684457.
Copy Download .nbib Format: NLM
Improving phlebotomy handover of untaken blood tests to junior doctors.

BMJ quality improvement reports

Brown E, Jarrett H, Churchhouse G, Hartley M, Cohen D, Kyprianou K, Murphy S, Walker B, Hill C.
PMID: 26734434
BMJ Qual Improv Rep. 2015 Aug 27;4(1). doi: 10.1136/bmjquality.u206278.w3267. eCollection 2015.

A lack of communication between junior doctors and phlebotomists means untaken blood tests are often not recognised until late in a junior doctor's day, resulting in additional hours worked, delays in patient management, and potentially avoidable handover of additional...

Cite
Brown E, Jarrett H, Churchhouse G, et al. Improving phlebotomy handover of untaken blood tests to junior doctors. BMJ Qual Improv Rep. 2015;4(1)doi: 10.1136/bmjquality.u206278.w3267.
Brown, E., Jarrett, H., Churchhouse, G., Hartley, M., Cohen, D., Kyprianou, K., Murphy, S., Walker, B., & Hill, C. (2015). Improving phlebotomy handover of untaken blood tests to junior doctors. BMJ quality improvement reports, 4(1), . https://doi.org/10.1136/bmjquality.u206278.w3267
Brown, Emily, et al. "Improving phlebotomy handover of untaken blood tests to junior doctors." BMJ quality improvement reports vol. 4,1 (2015). doi: https://doi.org/10.1136/bmjquality.u206278.w3267
Brown E, Jarrett H, Churchhouse G, Hartley M, Cohen D, Kyprianou K, Murphy S, Walker B, Hill C. Improving phlebotomy handover of untaken blood tests to junior doctors. BMJ Qual Improv Rep. 2015 Aug 27;4(1). doi: 10.1136/bmjquality.u206278.w3267. eCollection 2015. PMID: 26734434; PMCID: PMC4693092.
Copy Download .nbib Format: NLM
Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines.

Journal of Crohn's & colitis

Porter RJ, Arends MJ, Churchhouse AMD, Din S.
PMID: 34111282
J Crohns Colitis. 2021 Dec 18;15(12):2131-2141. doi: 10.1093/ecco-jcc/jjab102.

The cumulative impact of chronic inflammation in patients with inflammatory bowel diseases predisposes to the development of inflammatory bowel disease-associated colorectal cancer [IBD-CRC]. Inflammation can induce mutagenesis, and the relapsing-remitting nature of this inflammation, together with epithelial regeneration, may...

Cite
Porter RJ, Arends MJ, Churchhouse AMD, et al. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines. J Crohns Colitis. 2021;15(12):2131-2141doi: 10.1093/ecco-jcc/jjab102.
Porter, R. J., Arends, M. J., Churchhouse, A. M. D., & Din, S. (2021). Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines. Journal of Crohn's & colitis, 15(12), 2131-2141. https://doi.org/10.1093/ecco-jcc/jjab102
Porter, Ross J, et al. "Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines." Journal of Crohn's & colitis vol. 15,12 (2021): 2131-2141. doi: https://doi.org/10.1093/ecco-jcc/jjab102
Porter RJ, Arends MJ, Churchhouse AMD, Din S. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines. J Crohns Colitis. 2021 Dec 18;15(12):2131-2141. doi: 10.1093/ecco-jcc/jjab102. PMID: 34111282; PMCID: PMC8684457.
Copy Download .nbib Format: NLM
Rhabdomyolysis complicating percutaneous radiofrequency ablation of persistent atrial fibrillation.

HeartRhythm case reports

Churchhouse AMD, Whitaker J, Vaghela M, Rinaldi CA.
PMID: 28491540
HeartRhythm Case Rep. 2015 Jun 27;1(4):169-171. doi: 10.1016/j.hrcr.2015.01.013. eCollection 2015 Jul.

No abstract available.

Cite
Churchhouse AMD, Whitaker J, Vaghela M, et al. Rhabdomyolysis complicating percutaneous radiofrequency ablation of persistent atrial fibrillation. HeartRhythm Case Rep. 2015;1(4):169-171doi: 10.1016/j.hrcr.2015.01.013.
Churchhouse, A. M. D., Whitaker, J., Vaghela, M., & Rinaldi, C. A. (2015). Rhabdomyolysis complicating percutaneous radiofrequency ablation of persistent atrial fibrillation. HeartRhythm case reports, 1(4), 169-171. https://doi.org/10.1016/j.hrcr.2015.01.013
Churchhouse, Antonia Maria Diane, et al. "Rhabdomyolysis complicating percutaneous radiofrequency ablation of persistent atrial fibrillation." HeartRhythm case reports vol. 1,4 (2015): 169-171. doi: https://doi.org/10.1016/j.hrcr.2015.01.013
Churchhouse AMD, Whitaker J, Vaghela M, Rinaldi CA. Rhabdomyolysis complicating percutaneous radiofrequency ablation of persistent atrial fibrillation. HeartRhythm Case Rep. 2015 Jun 27;1(4):169-171. doi: 10.1016/j.hrcr.2015.01.013. eCollection 2015 Jul. PMID: 28491540; PMCID: PMC5419246.
Copy Download .nbib Format: NLM
Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines.

Journal of Crohn's & colitis

Porter RJ, Arends MJ, Churchhouse AMD, Din S.
PMID: 34111282
J Crohns Colitis. 2021 Jun 10; doi: 10.1093/ecco-jcc/jjab102. Epub 2021 Jun 10.

The cumulative impact of chronic inflammation in patients with inflammatory bowel diseases predisposes to the development of inflammatory bowel disease-associated colorectal cancer (IBD-CRC). Inflammation can induce mutagenesis and the relapsing-remitting nature of this inflammation, together with epithelial regeneration, may...

Cite
Porter RJ, Arends MJ, Churchhouse AMD, et al. Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines. J Crohns Colitis. 2021;doi: 10.1093/ecco-jcc/jjab102.
Porter, R. J., Arends, M. J., Churchhouse, A. M. D., & Din, S. (2021). Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines. Journal of Crohn's & colitis, . https://doi.org/10.1093/ecco-jcc/jjab102
Porter, Ross J, et al. "Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines." Journal of Crohn's & colitis vol. (2021). doi: https://doi.org/10.1093/ecco-jcc/jjab102
Porter RJ, Arends MJ, Churchhouse AMD, Din S. Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines. J Crohns Colitis. 2021 Jun 10; doi: 10.1093/ecco-jcc/jjab102. Epub 2021 Jun 10. PMID: 34111282.
Copy Download .nbib Format: NLM
Publisher Correction: Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein.

Nature neuroscience

Farhan SMK, Howrigan DP, Abbott LE, Klim JR, Topp SD, Byrnes AE, Churchhouse C, Phatnani H, Smith BN, Rampersaud E, Wu G, Wuu J, Shatunov A, Iacoangeli A, Khleifat AA, Mordes DA, Ghosh S, Eggan K, Rademakers R, McCauley JL, Schüle R, Züchner S, Benatar M, Taylor JP, Nalls M, Gotkine M, Shaw PJ, Morrison KE, Al-Chalabi A, Traynor B, Shaw CE, Goldstein DB, Harms MB, Daly MJ, Neale BM.
PMID: 31857710
Nat Neurosci. 2020 Feb;23(2):295. doi: 10.1038/s41593-019-0570-5.

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite
Farhan SMK, Howrigan DP, Abbott LE, et al. Publisher Correction: Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein. Nat Neurosci. 2020;23(2):295doi: 10.1038/s41593-019-0570-5.
Farhan, S. M. K., Howrigan, D. P., Abbott, L. E., Klim, J. R., Topp, S. D., Byrnes, A. E., Churchhouse, C., Phatnani, H., Smith, B. N., Rampersaud, E., Wu, G., Wuu, J., Shatunov, A., Iacoangeli, A., Khleifat, A. A., Mordes, D. A., Ghosh, S., Eggan, K., Rademakers, R., McCauley, J. L., Schüle, R., Züchner, S., Benatar, M., Taylor, J. P., Nalls, M., Gotkine, M., Shaw, P. J., Morrison, K. E., Al-Chalabi, A., Traynor, B., Shaw, C. E., Goldstein, D. B., Harms, M. B., Daly, M. J., & Neale, B. M. (2020). Publisher Correction: Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein. Nature neuroscience, 23(2), 295. https://doi.org/10.1038/s41593-019-0570-5
Farhan, Sali M K, et al. "Publisher Correction: Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein." Nature neuroscience vol. 23,2 (2020): 295. doi: https://doi.org/10.1038/s41593-019-0570-5
Farhan SMK, Howrigan DP, Abbott LE, Klim JR, Topp SD, Byrnes AE, Churchhouse C, Phatnani H, Smith BN, Rampersaud E, Wu G, Wuu J, Shatunov A, Iacoangeli A, Khleifat AA, Mordes DA, Ghosh S, Eggan K, Rademakers R, McCauley JL, Schüle R, Züchner S, Benatar M, Taylor JP, Nalls M, Gotkine M, Shaw PJ, Morrison KE, Al-Chalabi A, Traynor B, Shaw CE, Goldstein DB, Harms MB, Daly MJ, Neale BM. Publisher Correction: Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein. Nat Neurosci. 2020 Feb;23(2):295. doi: 10.1038/s41593-019-0570-5. PMID: 31857710.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries